Skip to main content
SpringerLink
Log in

Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Recently, several reports addressed the associations of adiponectin (ADIPOQ) gene polymorphisms with abnormal adiponectin serum levels, type 2 diabetes mellitus (T2DM), and diabetic nephropathy (DN); however, results are inconsistent. This study aimed to investigate the possible association of ADIPOQ gene polymorphisms with T2DM and/or DN and whether they affect serum adiponectin levels in Egyptian population. Two hundred and ninety-six T2DM patients (100 normoalbuminuric patients, 103 microalbuminuric patients, and 93 macroalbuminuric patients) and 209 controls were enrolled in the present study. Polymorphisms of +45, −11391, and +276 of the ADIPOQ gene were detected using polymerase chain reaction restriction fragment length polymorphism. Serum adiponectin was measured using ELISA. Our results revealed that ADIPOQ +45 TG and GG genotypes and G allele were significantly associated with T2DM, micro/macroalbuminuria, and decreased serum adiponectin level. ADIPOQ −11391 AA genotype frequency was significantly increased in T2DM group. Moreover, GA and AA genotypes and A allele of ADIPOQ −11391 were significantly associated with susceptibility to macroalbuminuria despite increased serum adiponectin concentrations. While, ADIPOQ +276 TT genotype and T allele were protective factors regarding the susceptibility to T2DM and micro/macroalbuminuria, and they were significantly associated with increased adiponectin levels. We observed also that the decrease of the serum Adiponectin level was accompanied by an insulin resistance, albuminuria, as well as an increase of serum creatinine. We concluded that ADIPOQ +45; ADIPOQ −11391 gene polymorphisms are associated with T2DM and/or DN in Egyptian population. While, ADIPOQ +276 gene polymorphism is a protective factor regarding T2DM and/or DN susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kronenberg F (2008) Genome-wide association studies in aging related processes such as diabetes mellitus, atherosclerosis and cancer. Exp Gerontol 43:39–43

    Article  PubMed  CAS  Google Scholar 

  2. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S et al (2000) Genome wide search for type 2 diabetes susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21q24. Am J Hum Genet 67:1470–1480

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Hasslacher C, Ritz E, Wahl P, Michael C (1989) Similar risks of nephropathy in patients with type 1 or type 2 diabetes mellitus. Nephrol Dial Transplant 4:859–863

    PubMed  CAS  Google Scholar 

  4. Gordosi A, Scuffham P, Shearer A, Oglesby A (2004) The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complicat 18:18–26

    Article  Google Scholar 

  5. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 3106:356–360

    Article  Google Scholar 

  6. Hopkins TA, Ouchi N, Shibata R, Walsh K (2007) Adiponectin actions in the cardiovascular system. Cardiovasc Res 74(1):11–18

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR et al (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118(5):1645–1656

    PubMed Central  PubMed  CAS  Google Scholar 

  8. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K et al (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51(2):536–540

    Article  PubMed  CAS  Google Scholar 

  9. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M et al (2000) Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24:861–868

    Article  PubMed  CAS  Google Scholar 

  10. Menzaghi C, Trischitta V, Doria A (2007) Genetic influences of adiponectin on insulin resistance, type 2 diabetes and cardiovascular disease. Diabetes 56:1198–1209

    Article  PubMed  CAS  Google Scholar 

  11. Szopa M, Malczewska-Malec M, Kiec-Wilk B, Skupien J, Wolkow P, Malecki MT et al (2009) Variants of the adiponectin gene and type 2 diabetes in a polish population. Acta Diabetol 46(4):317–322

    Article  PubMed  CAS  Google Scholar 

  12. American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31:55–60

    Article  CAS  Google Scholar 

  13. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

    Article  Google Scholar 

  14. Komaba H, Igaki N, Goto S, Yokota K, Doi H, Takemoto T (2006) Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 26(5):476–482

    Article  PubMed  CAS  Google Scholar 

  15. Sabouri S, Ghayour-Mobarhan M, Moohebati M, Hassani M, Kassaeian J, Tatari F et al (2011) Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. Sci World J 11:93–101

    Google Scholar 

  16. Shirin HR, Mahsa MA, Mohammadali S, Parisa PA, Mahsa N, Ramin H et al (2011) Genetic association analysis of the adiponectin polymorphisms in type 2 diabetes with and without complications. Iranian J Diabetes Lipid Disorders 10:1–4

    Google Scholar 

  17. Zhang N, Shi YH, Hao CF, Gu HF, Li Y, Zhao YR et al (2008) Association of +45G15G (T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. Eur J Endocrinol 158(2):255–260

    Article  PubMed  CAS  Google Scholar 

  18. Li S, Li L, Li K, Qi X, Hoekema D, Liu H et al (2004) Association of adipose most abundant transcript 1 gene (apM1) with type 2 diabetes mellitus in a Chinese population: a meta-analysis of case–control studies. Clin Endocrinol (Oxf) 68:885–889

    Article  CAS  Google Scholar 

  19. Li LL, Kang XL, Ran XJ, Wang Y, Wang CH, Huang L et al (2007) Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol 34:1287–1290

    Article  PubMed  CAS  Google Scholar 

  20. Zacharova J, Chiasson JL, Laakso M (2005) STOP-NIDDM study group the common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP+276 of the of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 54:893–899

    Article  PubMed  CAS  Google Scholar 

  21. Gu HF, Abulaiti A, Ostenson CG, Humphreys K, Wahlestedt C, Brookes AJ et al (2004) Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53(1):31–35

    Article  Google Scholar 

  22. Vasseur F, Helbecque N, Lobbens S, Vasseur-Delannoy V, Dina C, Clément K et al (2005) Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 48:892–899

    Article  PubMed  CAS  Google Scholar 

  23. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ et al (2011) Associations between single-nucleotide polymorphisms (+45T > G, +276G > T, −11377C > G, −11391G > A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54:2303–2314

    Article  PubMed  CAS  Google Scholar 

  24. Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S et al (2004) Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance prospective study. Diabetes 53(4):1150–1157

    Article  PubMed  CAS  Google Scholar 

  25. Roszkowska-Gancarz M, Bartoszewicz Z, Polosak J, Kurylowicz A, Jonas M, Mossakowska M et al (2012) Total and high molecular weight adiponectin and level-modifying polymorphisms of ADIPOQ in centenarians. Endokrynologia Polska 63(6):439–446

    PubMed  CAS  Google Scholar 

  26. Olckers A, Towers GW, van der Merwe A, Schwarz PE, Rheeder P, Schutte AE (2007) Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 56(5):587–592

    Article  PubMed  CAS  Google Scholar 

  27. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D et al (2005) The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54(5):1607–1610

    Article  PubMed  CAS  Google Scholar 

  28. Mousavinasab F, Ta¨htinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J et al (2006) Commom polymorphisms (single-nucleotide polymorphysims SNP+45 and SNP+276 of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 87(2):147–151

    Article  PubMed  CAS  Google Scholar 

  29. Jang Y, Lee JH, Chae JS, Kim OY, Koh SJ, Kim JY et al (2005) Association of 276 G > T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 82(4):760–767

    PubMed  CAS  Google Scholar 

  30. Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ et al (2005) Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet Med 22:569–575

    Article  PubMed  CAS  Google Scholar 

  31. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S et al (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607–2614

    Article  PubMed  CAS  Google Scholar 

  32. Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A et al (2004) Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53:209–213

    Article  PubMed  CAS  Google Scholar 

  33. Populaire C, Mori Y, Dina C, Vasseur F, Vaxillaire M, Kadowaki et al (2003) Does the −11377 promoter variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families? Diabetologia 46:443–445

    PubMed  CAS  Google Scholar 

  34. Xu MT, Chen XC, Jin LZ, Chen WQ (2008) A meta-analysis on the association between adiponectin gene 45T/G +276G/T polymorphisms and type 2 diabetes in Chinese population. Zhonghua Liu Xing Bing Xue Za Zhi 29:1132–1136

    PubMed  CAS  Google Scholar 

  35. Kacso IM, Farcas MF, Pop IV, Bondor CI, Potra AR, Moldovan D et al (2012) 267 G > T polymorphism of the ADIPOQ gene influences plasma adiponectin in type 2 diabetes patients but is not predictive for presence of in type 2 diabetes in a Caucasian Cohort from Romania. Maedica (Buchar). 7(4):271–276

    PubMed Central  PubMed  Google Scholar 

  36. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE et al (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306–2312

    Article  PubMed  CAS  Google Scholar 

  37. Wang Y, Zhang D, Liu Y, Yang Y, Zhao T, Xu J et al (2009) Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. J Genet Genomics 36:417–423

    Article  PubMed  CAS  Google Scholar 

  38. Vendramini MF, Pereira AC, Ferreira SR, Kasamatsu TS, Moises RS (2010) Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians. J Diabetes Complicat 24:115–120

    Article  PubMed  Google Scholar 

  39. Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW (2009) Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 58:499–504

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  40. Gu HF (2009) Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms. Biomark Insights 4:123–133

    PubMed Central  PubMed  CAS  Google Scholar 

  41. Yang WS, Hsiung CA, Ho LT, Chen YT, He CT, Curb JD et al (2003) Genetic epistasis of adiponectin and PPAR gamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia 46:977–983

    Article  PubMed  CAS  Google Scholar 

  42. Gonzalez-Sanchez JL, Zebena CA, Martinez-Larrad MT, Fernández-Pérez C, Pérez-Barba M, Laakso M et al (2005) An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13:807

    Article  PubMed  CAS  Google Scholar 

  43. Jaziri R, Aubert R, Roussel R, Emery N, Maimaitiming S, Bellili N et al (2010) Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. Nephrol Dial Transplant 25(7):2231–2237

    Article  PubMed  CAS  Google Scholar 

  44. Menzaghi C, Ercolino T, Salvemini L, Coco A, Kim SH, Fini G et al (2004) Multigenic control of serum adiponectin levels. Evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 19:170–174

    Article  PubMed  CAS  Google Scholar 

  45. Kacso IM, Trifa AP, Popp RA, Kasco G (2012) Association of 276G > T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients Int Urol Nephrol (2012). Int Urol Nephrol 44(6):1771–1777

    Article  PubMed  CAS  Google Scholar 

  46. Ma J, Möllsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S et al (2007) Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. J Diabetes Complicat 21:28–33

    Article  PubMed  Google Scholar 

  47. Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG et al (2004) Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89:4010–4017

    Article  PubMed  CAS  Google Scholar 

  48. Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F (2007) MMKD Study Group. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the mild to moderate kidney disease study. Kidney Int 71:1279–1286

    Article  PubMed  CAS  Google Scholar 

  49. Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD (2006) EURODIAB Prospective Complications Study Group. For the EURODIAB Prospective Complications Study Group. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 91:129–135

    Article  PubMed  CAS  Google Scholar 

  50. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J et al (2005) Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 28:1410–1414

    Article  PubMed  CAS  Google Scholar 

  51. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K et al (2007) Adiponectin deficiency increases leukocyte endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 117(6):1718–1726

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  52. Lenghel AR, Kacso IM, Bondor CI, Rusu C, Rahaian R, Gherman Caprioara M (2012) Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients. Diab Diabetes Res Clin Pract 95(1):55–61

    Article  CAS  Google Scholar 

  53. Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW et al (2009) Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 58(2):499–504

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  54. Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T et al (2008) Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant 23(5):1621–1627

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of interest

None declared.

Ethical approval

The study protocol was approved by a medical ethics committee of Faculty of Medicine, Zagazig University.

Author information

Authors and Affiliations

  1. Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Amal S. El-Shal & Haidy E. Zidan

  2. Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Nearmeen M. Rashad

Authors
  1. Amal S. El-Shal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haidy E. Zidan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nearmeen M. Rashad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amal S. El-Shal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Shal, A.S., Zidan, H.E. & Rashad, N.M. Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy. Mol Biol Rep 41, 2287–2298 (2014). https://doi.org/10.1007/s11033-014-3082-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3082-0

Keywords

Search

Navigation